참당귀

A 12-Week, Single-Centre, Randomised, Double-Blind, Placebo-Controlled, Parallel-Design Clinical Trial for the Evaluation of the Efficacy and Safety of Lactiplantibacillus plantarum SKO-001 in Reducing Body Fat.

1. Nutrients. 2024 Apr 11;16(8):1137. doi: 10.3390/nu16081137. A 12-Week, Single-Centre, Randomised, Double-Blind, Placebo-Controlled, Parallel-Design Clinical Trial for the Evaluation of the Efficacy and Safety of Lactiplantibacillus plantarum SKO-001 in Reducing Body Fat. Shin SM(1), Park JS(2

JI-CJ002, a Natural Herbal Formula, Enhances the Antitumor Efficacy of FOLFOX in Colorectal Cancer by Suppressing the DDR Pathway.

2. Anticancer Res. 2025 Nov;45(11):4987-5000. doi: 10.21873/anticanres.17841. JI-CJ002, a Natural Herbal Formula, Enhances the Antitumor Efficacy of FOLFOX in Colorectal Cancer by Suppressing the DDR Pathway. Kim MW(#)(1), Kim D(#)(1), Lee SE(1), Ahn J(1), Park B(1), Cheon C(1)(2)(3), Ko SG(4)(2

Safety Evaluation of SH003 and Docetaxel Combination in Patients With Breast and Lung Cancer: A Multi-Center, Open-Label, Dose Escalation Phase I Clinical Trial.

3. Integr Cancer Ther. 2025 Jan-Dec;24:15347354251363892. doi: 10.1177/15347354251363892. Epub 2025 Aug 9. Safety Evaluation of SH003 and Docetaxel Combination in Patients With Breast and Lung Cancer: A Multi-Center, Open-Label, Dose Escalation Phase I Clinical Trial. Cheon C(1), Kim H(2), Kang

Efficacy and safety of SH003 on immune function: study protocol for a randomized, double-blind placebo-controlled clinical trial.

4. BMC Complement Med Ther. 2025 Jul 30;25(1):293. doi: 10.1186/s12906-025-05032-4. Efficacy and safety of SH003 on immune function: study protocol for a randomized, double-blind placebo-controlled clinical trial. Cheon C(1), Ko SG(2). Author information: (1)Department of Preventive Medicine, Co

Angelica gigas Nakai (Korean Dang-gui) Root Alcoholic Extracts in Health Promotion and Disease Therapy - active Phytochemicals and In Vivo Molecular Targets.

5. Pharm Res. 2025 Jan;42(1):25-47. doi: 10.1007/s11095-024-03809-9. Epub 2025 Jan 8. Angelica gigas Nakai (Korean Dang-gui) Root Alcoholic Extracts in Health Promotion and Disease Therapy - active Phytochemicals and In Vivo Molecular Targets. Lü J(1)(2)(3), Jiang C(4)(5), Drabick JJ(6)(7), Jos

State of the Art and Future Implications of SH003: Acting as a Therapeutic Anticancer Agent.

6. Cancers (Basel). 2022 Feb 21;14(4):1089. doi: 10.3390/cancers14041089. State of the Art and Future Implications of SH003: Acting as a Therapeutic Anticancer Agent. Lee K(1), Youn BY(1), Choi YJ(2), Moon S(3), Im J(3), Cho K(3), Ko SG(1), Cheon C(1). Author information: (1)Department of Preve

Phase I study to evaluate the maximum tolerated dose of the combination of SH003 and docetaxel in patients with solid cancer: A study protocol.

7. Medicine (Baltimore). 2020 Sep 18;99(38):e22228. doi: 10.1097/MD.0000000000022228. Phase I study to evaluate the maximum tolerated dose of the combination of SH003 and docetaxel in patients with solid cancer: A study protocol. Cheon C(1), Ko SG. Author information: (1)Department of Preventiv

A Phase I Study to Evaluate the Safety of the Herbal Medicine SH003 in Patients With Solid Cancer.

8. Integr Cancer Ther. 2020 Jan-Dec;19:1534735420911442. doi: 10.1177/1534735420911442. A Phase I Study to Evaluate the Safety of the Herbal Medicine SH003 in Patients With Solid Cancer. Cheon C(1), Ko SG(1). Author information: (1)Department of Korean Preventive Medicine, College of Korean Med

A Randomized, Double-Blind, Placebo-Controlled Clinical Trial Assessing the Effects of Angelica Gigas Nakai Extract on Blood Triglycerides.

9. Nutrients. 2020 Jan 31;12(2):377. doi: 10.3390/nu12020377. A Randomized, Double-Blind, Placebo-Controlled Clinical Trial Assessing the Effects of Angelica Gigas Nakai Extract on Blood Triglycerides. Jung SJ(1)(2), Kim WR(1)(3), Oh MR(1), Cha YS(3), Park BH(4), Chae SW(1)(2)(5). Author informa

Single-arm, open-label, dose-escalation phase I study to evaluate the safety of a herbal medicine SH003 in patients with solid cancer: a study protocol.

10. BMJ Open. 2018 Aug 5;8(8):e019502. doi: 10.1136/bmjopen-2017-019502. Single-arm, open-label, dose-escalation phase I study to evaluate the safety of a herbal medicine SH003 in patients with solid cancer: a study protocol. Cheon C(1), Kang S(1), Ko Y(1), Kim M(2), Jang BH(1), Shin YC(1), Ko SG

Herbal therapeutics for female infertility: A systematic review and meta-analysis.

11. J Ethnopharmacol. 2024 Jan 30;319(Pt 2):117258. doi: 10.1016/j.jep.2023.117258. Epub 2023 Sep 29. Herbal therapeutics for female infertility: A systematic review and meta-analysis. Hyun JY(1), Jung HS(2), Park JY(3). Author information: (1)College of Korean Medicine, Daejeon University, Dae